Skip to main content
. 2018 Oct 14;4:542–555. doi: 10.1016/j.trci.2018.09.001

Fig. 1.

Fig. 1

The cognitive decline in set 1 patients by different aHTN treatment groups was analyzed using a mixed-effect regression model. Combination of diuretics, calcium channel blockers, and renin-angiotensin-aldosterone system inhibitors (diuretics + CCB + RAAS) was associated with the slowest rate of cognitive decline among all groups tested (Δβ = +1.46, P < .0001). This effect was most prominent in the first 3 years of aHTN treatment. Abbreviations: aHTN, antihypertensive; MMSE, Mini-Mental State Examination.